|
TANC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.837000E-04 |
| Normal-vs-Stage3 |
6.65023591750469E-14 |
| Normal-vs-Stage4 |
3.68309827081248E-11 |
| Stage1-vs-Stage2 |
6.000600E-01 |
| Stage1-vs-Stage3 |
5.574100E-02 |
| Stage1-vs-Stage4 |
1.526250E-01 |
| Stage2-vs-Stage3 |
1.198820E-01 |
| Stage2-vs-Stage4 |
1.590420E-01 |
| Stage3-vs-Stage4 |
9.173200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
4.07780000000191E-06 |
| Normal-vs-Asian |
3.6187999999937E-06 |
| Caucasian-vs-AfricanAmerican |
4.281200E-01 |
| Caucasian-vs-Asian |
4.638000E-01 |
| AfricanAmerican-vs-Asian |
2.480000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.50435261206894E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.202300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6251444634463E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.46989997951152E-09 |
| Normal-vs-Age(81-100Yrs) |
4.861400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.349800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.831200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.142600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.345400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.745600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.213400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.758100E-02 |
| Classical-VS-Follicular |
4.12620049239365E-10 |
| Classical-VS-Other |
1.776440E-02 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
5.92969999999582E-05 |
| Tall-VS-Other |
1.085970E-02 |
| Tall-VS-Normal |
1.91020000039899E-07 |
| Follicular-VS-Other |
5.688000E-01 |
| Follicular-VS-Normal |
2.537800E-03 |
| Other-VS-Normal |
5.930000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.79078973872038E-12 |
| Normal-vs-N1 |
2.802399999835E-07 |
| N0-vs-N1 |
4.995400E-01 |
|
|
